Avandia Market Share Stabilizing, GSK CEO Garnier Says
In his last earnings presentation, Garnier says it is unclear whether the type 2 diabetes drug will become a growth driver again.
In his last earnings presentation, Garnier says it is unclear whether the type 2 diabetes drug will become a growth driver again.